1. Epidermal Growth Factor: A Critical Factor in Fetal Maturation?
- Author
-
Michael J. Waters, D. Buntine, I. R. Young, G. D. Thorburn, P. S. Hopkins, and M. Dolling
- Subjects
Cortisol secretion ,endocrine system ,medicine.medical_specialty ,Fetus ,Thyroid ,Anatomy ,Reverse triiodothyronine ,Thyrotropin receptor ,Muscle hypertrophy ,chemistry.chemical_compound ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Epidermal growth factor ,Internal medicine ,medicine ,Placental lactogen - Abstract
Epidermal growth factor (EGF) infused over 3-14 days into fetal sheep of 110-125 days gestation resulted in a number of morphological and endocrine changes. Striking hypertrophy of the skin, wool follicles and their accessory structures was seen, together with a reduction in the ratio of secondary to primary follicles and degenerative changes in wool fibres associated with shedding of fibres. Adrenal, thyroid, liver and kidney weights were increased while thymus weight was decreased. The increase in adrenal size resulted from cortical hypertrophy and was associated with increased cortisol secretion. Thyroid hypertrophy was accompanied by an increase in colloid stores, decreased plasma thyroxine and reverse triiodothyronine (T3) concentrations, unchanged plasma T3 and thyroid-binding globulin and raised thyrotropin (TSH) levels. Thyrotropin receptor affinity and content per gram of tissue were unchanged. Fetal and maternal plasma prolactin and growth hormone levels, and fetal plasma placental lactogen levels, were unchanged, although there was a significant rise in maternal plasma placental lactogen concentrations with high doses of EGF. Other maturational parameters such as switching from fetal to adult haemoglobin and liver glycogen content were unaffected.
- Published
- 2008
- Full Text
- View/download PDF